Atkinson Edward Morrow III 4

What Happened

• Edward M. Atkinson III, EVP & Chief Technical Operations Officer at Vertex Pharmaceuticals (VRTX), disposed of 1,903 shares on Feb 13, 2026. The shares were reported at $487.76 per share, totaling approximately $928,207.28. The transaction is coded as "F" on the Form 4, indicating the shares were surrendered/used to satisfy tax withholding or pay exercise price — a routine administrative disposition rather than an open-market sale for investment reasons.

Key Details

• Transaction date: 2026-02-13; reported filing date: 2026-02-18 (appears to be filed after the standard two-business-day window).
• Price per share: $487.76; total value: ~$928,207.28.
• Transaction code: F — payment of exercise price or tax liability (shares withheld/surrendered).
• Shares owned after transaction: not specified in the provided filing details.
• No 10b5-1 plan or other special instructions were noted in the supplied summary.

Context

• Code F typically means shares were surrendered to cover taxes from an option exercise or vesting event (a form of tax withholding). This is a routine administrative action and does not necessarily signal a change in the insider’s view of the company. The filing date suggests the Form 4 was submitted after the usual two-business-day reporting window, which investors may note when tracking timeliness of insider disclosures.